2CBFly-NBOMe

2CBFly-NBOMe

Names
Preferred IUPAC name 2-(8-Bromo-2,3,6,7-tetrahydrobenzo[1,2-b:4,5-b′]difuran-4-yl)-N-[(2-methoxyphenyl)methyl]ethan-1-amine
Identifiers
CAS Number	1335331-42-4 Y[chemspider]
3D model (JSmol)	Interactive image Interactive image
Abbreviations	2CBFly-NBOMe
ChemSpider	26234936 Y
PubChem CID	57469208
CompTox Dashboard (EPA)	DTXSID40726752
InChI InChI=1S/C20H22BrNO3/c1-23-17-5-3-2-4-13(17)12-22-9-6-14-15-7-10-25-20(15)18(21)16-8-11-24-19(14)16/h2-5,22H,6-12H2,1H3 Y Key: CUFCITSPWAZWHS-UHFFFAOYSA-N Y
SMILES COc1ccccc1CNCCc1c2CCOc2c(Br)c2CCOc12 COC1=C(CNCCC2=C3OCCC3=C(Br)C3=C2CCO3)C=CC=C1
Properties
Chemical formula	C20H22BrNO3
Molar mass	404.298 g/mol
Except where otherwise noted, data are given for materials in their standard state (at 25 °C [77 °F], 100 kPa). N verify (what is YN ?) Infobox references

2CBFly-NBOMe (NBOMe-2C-B-FLY, Cimbi-31) is a compound indirectly derived from the phenethylamine hallucinogen 2C-B, and related to benzodifurans like 2C-B-FLY and N-benzylphenethylamines like 25I-NBOMe. It was discovered in 2002, and further researched by Ralf Heim at the Free University of Berlin, and subsequently investigated in more detail by a team at Purdue University led by David E. Nichols. It acts as a potent partial agonist for the 5HT_2A serotonin receptor subtype.

Analogues and derivatives

Legality

United Kingdom

This substance is a Class A drug in the United Kingdom as a result of the N-benzylphenethylamine catch-all clause in the Misuse of Drugs Act 1971.

United States

2CBFly-NBOMe is a controlled substance in Vermont as of January 2016.